IL219927A0 - Mybl2 peptides and vaccines containing the same - Google Patents

Mybl2 peptides and vaccines containing the same

Info

Publication number
IL219927A0
IL219927A0 IL219927A IL21992712A IL219927A0 IL 219927 A0 IL219927 A0 IL 219927A0 IL 219927 A IL219927 A IL 219927A IL 21992712 A IL21992712 A IL 21992712A IL 219927 A0 IL219927 A0 IL 219927A0
Authority
IL
Israel
Prior art keywords
same
vaccines containing
mybl2
peptides
mybl2 peptides
Prior art date
Application number
IL219927A
Other languages
English (en)
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of IL219927A0 publication Critical patent/IL219927A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL219927A 2009-12-04 2012-05-22 Mybl2 peptides and vaccines containing the same IL219927A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26687109P 2009-12-04 2009-12-04
PCT/JP2010/007028 WO2011067933A1 (en) 2009-12-04 2010-12-02 Mybl2 peptides and vaccines containing the same

Publications (1)

Publication Number Publication Date
IL219927A0 true IL219927A0 (en) 2012-07-31

Family

ID=44114795

Family Applications (1)

Application Number Title Priority Date Filing Date
IL219927A IL219927A0 (en) 2009-12-04 2012-05-22 Mybl2 peptides and vaccines containing the same

Country Status (14)

Country Link
US (1) US20120328638A1 (enExample)
EP (1) EP2507257A4 (enExample)
JP (1) JP2013512659A (enExample)
KR (1) KR20120114284A (enExample)
CN (1) CN102753567A (enExample)
AU (1) AU2010327891A1 (enExample)
BR (1) BR112012013371A2 (enExample)
CA (1) CA2782484A1 (enExample)
IL (1) IL219927A0 (enExample)
MX (1) MX2012006376A (enExample)
RU (1) RU2012127762A (enExample)
SG (1) SG181108A1 (enExample)
TW (1) TW201200525A (enExample)
WO (1) WO2011067933A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108623657B (zh) * 2018-05-11 2021-02-12 苏州大学 多肽、重组dna分子、重组载体、外泌体及其应用
WO2024209270A2 (en) * 2023-04-07 2024-10-10 Infinitopes Limited Methods and compositions for cancer treatment using recombinant polypeptides
CN119859688A (zh) * 2025-01-20 2025-04-22 杭州树源生命科学有限公司 环状RNA Hsa_circ_0006332在食管鳞状细胞癌诊断和治疗中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103073620B (zh) * 2002-09-12 2014-12-10 肿瘤疗法科学股份有限公司 Kdr肽和包括该肽的疫苗
CN100352842C (zh) * 2002-10-31 2007-12-05 詹森药业有限公司 对促肾上腺皮质激素释放激素刺激的应答而表达增加的基因
US7847060B2 (en) * 2005-02-25 2010-12-07 Oncotherapy Science, Inc. Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
TW200908998A (en) * 2007-06-27 2009-03-01 Oncotherapy Science Inc Compositions and methods of treating cancer
TW201000119A (en) * 2008-06-10 2010-01-01 Oncotherapy Science Inc MYBL2 epitope peptides and vaccines containing the same

Also Published As

Publication number Publication date
SG181108A1 (en) 2012-07-30
EP2507257A1 (en) 2012-10-10
US20120328638A1 (en) 2012-12-27
MX2012006376A (es) 2012-07-10
AU2010327891A1 (en) 2012-06-21
BR112012013371A2 (pt) 2016-12-13
EP2507257A4 (en) 2013-04-03
TW201200525A (en) 2012-01-01
RU2012127762A (ru) 2014-01-10
CN102753567A (zh) 2012-10-24
CA2782484A1 (en) 2011-06-09
KR20120114284A (ko) 2012-10-16
JP2013512659A (ja) 2013-04-18
WO2011067933A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
IL209967A0 (en) Cdca1 epitope peptides and vaccines containing the same
IL214435A0 (en) Foxm1 peptides and vaccines containing the same
IL220752A0 (en) Tem8 peptides and vaccines comprising the same
IL209869A0 (en) Iqgap3 epitope peptides and vaccines containing the same
IL209870A0 (en) Mybl2 epitope peptides and vaccines containing the same
IL229926A (en) 3neil peptides and vaccines containing them
ZA201207416B (en) Cdca5 peptides and vaccines including the same
IL212046A0 (en) Rab6kifl/kif20a epitope peptide and vaccines containing the same
ZA201303886B (en) Tomm34 peptides and vaccines including the same
IL214453A0 (en) Vangli peptides and vaccines including the same
IL213318A0 (en) C1orf59 peptides and vaccines including the same
IL219927A0 (en) Mybl2 peptides and vaccines containing the same
IL215268A0 (en) C6orf167 peptides and vaccines containing the same
IL220146A0 (en) Tmem22 peptides and vaccines including the same
IL221474A0 (en) Hjurp peptides and vaccines including the same
ZA201207342B (en) Ect2 peptides and vaccines including the same
ZA201104890B (en) Wdrpuh epitope peptides and vaccines containing the same
IL225552A0 (en) wdhd1 peptides and vaccines containing them
IL225553A0 (en) 54orf18c peptides and vaccines containing them
HK1172353A (en) Mybl2 peptides and vaccines containing the same
HK1166088A (zh) C6orf167肽及包含它的疫苗
HK1186213A (en) Ttll4 peptides and vaccines containing the same
HK1170747A (en) Tmem22 peptides and vaccines including the same
HK1166096A (en) Vangl1 peptides and vaccines including the same
HK1154875A (en) Mybl2 epitope peptides and vaccines containing the same